Protecting intellectual property rights in SELEX and aptamers

Tim Sampson

World Patent Information, 2003, vol. 25, issue 4, 343-349

Abstract: In an earlier article, the author explained the technology of a particular field of combinatorial chemistry--using artificial DNA/RNA sequences--aptamers--as the screening ligand, and the SELEX protocol for exposing an aptamer library to the desired target. In the present article the author explores the types of claims currently being sought and granted for this technology. He considers the relevant legislation, and sets out his views on the validity of various approaches to seeking effective patent protection in this emerging technology, and the ways that protection may develop. He also investigates the potential value of seeking registered design rights in this area.

Keywords: Aptamers; SELEX; protocol; Combinatorial; chemistry; Oligonucleotide; ligands; Process; patents; Product; patents; Product-by-process; patents; Design; right; Binding; footprint; Sequence; claims; Homologous; sequence; claims; Structure; claims (search for similar items in EconPapers)
Date: 2003
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0172-2190(03)00067-X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:worpat:v:25:y:2003:i:4:p:343-349

Ordering information: This journal article can be ordered from
http://www.elsevier.com/wps/find/supportfaq.cws_home/regional
http://www.elsevier. ... _01_ooc_1&version=01

Access Statistics for this article

World Patent Information is currently edited by Michael Blackman

More articles in World Patent Information from Elsevier
Bibliographic data for series maintained by Catherine Liu ().